Cyclin-dependent Kinase 4 Inhibitors [MoA] - N0000193921

Pharmacologic Class Information

Pharmacologic Code N0000193921
Pharmacologic Name Cyclin-dependent Kinase 4 Inhibitors
Pharmacologic Uses
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Cyclin-dependent Kinase 4 Inhibitors

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Cyclin-dependent Kinase 4 Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
73462-101Cosela Non-Proprietary Name: TrilaciclibInjection, Powder, Lyophilized, For SolutionIntravenousG1 Therapeutics, Inc.ACTIVE